Development of QSAR model for immunomodulatory activity of natural coumarinolignoids

Immunomodulation is the process of alteration in immune response due to foreign intrusion of molecules inside the body. Along with the available drugs, a large number of herbal drugs are promoted in traditional Indian treatments, for their immunomodulating activity. Natural coumarinolignoids isolated from the seeds of Cleome viscose have been recognized as having hepatoprotective action and have recently been tested preclinically for their immunomodulatory activity affecting both cell-mediated and humoral immune response. To explore the immunomodulatory compound from derivatives of coumarinolignoids, a quantitative structure activity relationship (QSAR) and molecular docking studies were performed. Theoretical results are in accord with the in vivo experimental data studied on Swiss albino mice. Immunostimulatory activity was predicted through QSAR model, developed by forward feed multiple linear regression method with leave-one-out approach. Relationship correlating measure of QSAR model was 99% (R2 = 0.99) and predictive accuracy was 96% (RCV2 = 0.96). QSAR studies indicate that dipole moment, steric energy, amide group count, lambda max (UV-visible), and molar refractivity correlates well with biological activity, while decrease in dipole moment, steric energy, and molar refractivity has negative correlation. Docking studies also showed strong binding affinity to immunomodulatory receptors.

[1]  L. Horwitz,et al.  Ovarian ablation alone promotes aortic intimal hyperplasia and accumulation of fibroblast growth factor. , 1998, Circulation.

[2]  D. Golenbock,et al.  LPS‐binding proteins and receptors , 1998, Journal of leukocyte biology.

[3]  S. Chattopadhyay,et al.  Structures of cleomiscosins, coumarinolignoids of cleome viscosa seeds , 1985 .

[4]  B. Giroir,et al.  Regulation of cytokine gene expression: tumor necrosis factor, interleukin-1, and the emerging biology of cytokine receptors. , 1995, New horizons.

[5]  Michael J. Waring,et al.  The Search for New Anticancer Drugs , 1992, Cancer Biology and Medicine.

[6]  P. Selzer,et al.  Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.

[7]  S. Chattopadhyay,et al.  Modulation of inflammatory mediators by coumarinolignoids from Cleome viscosa in female swiss albino mice , 2008, Inflammopharmacology.

[8]  S. Vladimirov,et al.  Docking Studies and Anti-inflammatory Activity of β-Hydroxy-β-arylpropanoic Acids , 2008, Molecules.

[9]  A. Weiss,et al.  Phosphoinositide-dependent kinase 1 targets protein kinase A in a pathway that regulates interleukin 4 , 2006, The Journal of experimental medicine.

[10]  D. Weissman,et al.  Inhibition of Toll-like Receptor and Cytokine Signaling—A Unifying Theme in Ischemic Tolerance , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  N. Bhatt,et al.  Ayurveda and Traditional Chinese Medicine: A Comparative Overview , 2005, Evidence-based complementary and alternative medicine : eCAM.

[12]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[13]  A. K. Kukreja,et al.  Analysis of taxol and major taxoids in Himalayan yew, Taxus wallichiana. , 1999, Journal of chromatography. A.

[14]  P. Allavena,et al.  Differential Expression and Regulation of Toll-Like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells1 , 2000, The Journal of Immunology.

[15]  D. Golenbock,et al.  The Antifungal Drug Amphotericin B Promotes Inflammatory Cytokine Release by a Toll-like Receptor- and CD14-dependent Mechanism* , 2003, Journal of Biological Chemistry.

[16]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[17]  Y. Martin,et al.  A general and fast scoring function for protein-ligand interactions: a simplified potential approach. , 1999, Journal of medicinal chemistry.

[18]  M. Fukuzawa,et al.  Recurrent acute pancreatitis caused by malrotation of the intestine and effective treatment with laparoscopic Ladd’s procedure , 2005, Pediatric Surgery International.

[19]  I. Muegge A knowledge-based scoring function for protein-ligand interactions: Probing the reference state , 2000 .

[20]  E. Williamson,et al.  Cutting edge: signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes. , 1998, Journal of immunology.

[21]  H. Wagner Search for plant derived natural products with immunostimulatory activity: recent advances , 1990 .

[22]  J. Topliss,et al.  QSAR model for drug human oral bioavailability. , 2000, Journal of medicinal chemistry.

[23]  U Norinder,et al.  Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[24]  O. Levy,et al.  Immunostimulatory activity of Toll-like receptor 8 agonists towards human leucocytes: basic mechanisms and translational opportunities. , 2007, Biochemical Society transactions.